Alors que les besoins de nouveaux antibiotiques sont criants et devraient naturellement attirer les investisseurs, trop peu d’innovation et de R&D sont faits dans le domaine de l’antibiorésistance. On fait face à ce que l’on appelle une défaillance de marché, dont la raison principale est liée à la nécessit ...
More than ever in 2022, the fight against antimicrobial resistance will have to call upon keyplayers who do not regularly interact. How to bring them together, or at least how to get them to know each other better remained an openquestion for many years, to which an answer has not yet been found. ...
In February 2021, a strategic industry contract was signed between the Ministries of Health, Industry and Research, and the healthcare industries. One of the 6 projects included in this interministerial contract is dedicated to the fight against antibiomicrobial resistance (AMR), in order to strengthen France’s AMR ecosys ...
The French interministerial roadmap for antibiotic resistance control, published in 2016, outlines 40 actions, in a "One Health" perspective - a global approach advocated by the World Health Organization (WHO) and the World Organisation for Animal Health (OIE). Seven ministries and many national agencies have commited to this project. Wit ...
At the time of writing in March 2020, the world is facing an escalating and unprecedented health crisis caused by the emergence of a novel virus: SARS-CoV-2. A period that coincides with the launch of our project to create the National Antibiotic Resistance portal. Although we have no treatments for this novel viru ...